cancer clinical trials in wynnewood, PA

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery

Mainline Health CCOP
Wynnewood, Pennsylvania 19096

Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

Lankenau Hospital
Wynnewood, Pennsylvania 19096

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Lankenau Cancer Center at Lankenau Hospital

Trial Locations
Lankenau Cancer Center at Lankenau Hospital
CCOP - Main Line Health

Cervical Cancer, Endometrial Cancer, Sarcoma

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

Lankenau Hospital
Wynnewood, Pennsylvania 19096

Breast Cancer

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

Lankenau Cancer Center at Lankenau Hospital

Trial Locations
Lankenau Cancer Center at Lankenau Hospital
CCOP - Main Line Health

Lung Cancer

Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

Lankenau Cancer Center at Lankenau Hospital

Trial Locations
Lankenau Cancer Center at Lankenau Hospital
CCOP - Main Line Health

Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Lankenau Cancer Center at Lankenau Hospital

Trial Locations
Lankenau Cancer Center at Lankenau Hospital
CCOP - Main Line Health

Colorectal Cancer

Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Lankenau Hospital
Wynnewood, Pennsylvania 19096

Light Chain Deposition Disease, Smoldering Multiple Myeloma

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

Lankenau Hospital
Wynnewood, Pennsylvania 19096

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer

Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma

Lankenau Cancer Center at Lankenau Hospital
Wynnewood, Pennsylvania 19096

Lymphoma

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

Lankenau Cancer Center at Lankenau Hospital
Wynnewood, Pennsylvania 19096

Head and Neck Cancer

Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Lankenau Cancer Center at Lankenau Hospital
Wynnewood, Pennsylvania 19096

Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Lankenau Cancer Center at Lankenau Hospital
Wynnewood, Pennsylvania 19096

Dysphagia, Lung Cancer, Pain, Esophagitis

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery

Lankenau Hospital

Trial Locations
Lankenau Hospital
Mainline Health CCOP

Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Lankenau Cancer Center at Lankenau Hospital

Trial Locations
Lankenau Cancer Center at Lankenau Hospital
CCOP - Main Line Health

Breast Cancer, Depression, Fatigue, Sleep Disorders

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

CCOP - Main Line Health
Wynnewood, Pennsylvania 19096

Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Lankenau Hospital

Trial Locations
Lankenau Hospital
Mainline Health CCOP

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer

Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer

Lankenau Medical Center, Radiation Oncology
Wynnewood, Pennsylvania 19096

Prostate Neoplasms

Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer

Lankenau Medical Center
Wynnewood, Pennsylvania 19096

Rectal Neoplasms

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-Small Cell Lung Cancer

Lankenau Hospital

Trial Locations
Lankenau Hospital
Mainline Health CCOP

Extensive Stage Small Cell Lung Cancer, Large Cell Lung Cancer, Metastatic Carcinoma of Unknown Primary, Neuroendocrine Carcinoma, Newly Diagnosed Carcinoma of Unknown Primary

Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme